Trevi Therapeutics Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Take-Two stock drops as GTA 6 leaks continue
- GameStop posts higher income despite revenue drop in Q2 2026
- At least eight die, 18 missing after ferry capsizes off North Cyprus
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- Wall St dips as rising oil prices, hawkish Fed bets pressure stocks
Trevi Therapeutics (TRVI) PT Raised to $23 at Oppenheimer
June 2, 2025 4:03 PM EDTOppenheimer analyst Leland Gershall raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $23.00 (from $20.00) while maintaining a Outperform rating.
The analyst comments "Further detail to this morning's positive topline Phase 2b announcement per the company's webcast with KOL and slides... More
